---
title: "LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282189270.md"
description: "LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal"
datetime: "2026-04-09T11:54:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282189270.md)
  - [en](https://longbridge.com/en/news/282189270.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282189270.md)
---

# LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal

LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal

### Related Stocks

- [LBRX.US](https://longbridge.com/en/quote/LBRX.US.md)

## Related News & Research

- [Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial | PLRZ Stock News](https://longbridge.com/en/news/286270030.md)
- [08:35 ETTineco Spotlights Smarter Cleaning Solutions as Allergy Season Peaks Across American Homes](https://longbridge.com/en/news/286913594.md)
- [Innate Pharma reports Q1 results](https://longbridge.com/en/news/286225966.md)
- [VIRGINIA RETIREMENT SYSTEMS ET Al Increases Stock Holdings in BridgeBio Pharma, Inc. $BBIO](https://longbridge.com/en/news/286643939.md)
- [Motley Fool names Coca-Cola, P&G, J&J as 20-year dividend kings](https://longbridge.com/en/news/286957643.md)